Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial

Abstract Background Low-dose naltrexone (LDN) is used widely as an off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with a high risk of bias have investigated the effect of LDN on pain associated with fibromyalgia in women, but larger and more methodolo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Karin Due Bruun, Kirstine Amris, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Anders Holsgaard-Larsen, Robin Christensen, Palle Toft
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2021-11-01
Serija:	Trials
Teme:	Fibromyalgia Pain Low dose naltrexone LDN RCT
Online dostop:	https://doi.org/10.1186/s13063-021-05776-7
Oznake:	Označite Brez oznak, prvi označite!